Home Introduction Our Clients Year in Review What's New Who's New Transactions
Practice Areas Attorneys Recruiting Publications Factors Software Contact Us Search
PUBLICATIONS Carter, Ledyard & Milburn
page 1
page 2
page 3
page 4
page 5

February 1999

TRADE ASSOCIATIONS
U.S. ANTITRUST GUIDELINES

This memorandum sets forth general guidelines to assist Trade Associations and their members in reducing the possibility of violating the U.S. antitrust laws while fulfilling the Associations' purposes of improving business conditions in their industries. These guidelines are necessarily general, however, because questions involving the antitrust laws can involve a wide range of circumstances, making it virtually impossible to issue guidelines that cover all the questions that may arise.

In addition, this memorandum is directed primarily towards the activities of the Association as an organization seeking to perform its stated purpose, not towards anticompetitive activities by the Association's members that are clearly outside the scope of the Association's purposes. That is, we have assumed that the Association's members will not use Association meetings to discuss prices, divide markets, or engage in other activities that would raise serious antitrust problems wholly apart from the Association. In so doing, we assume that counsel for each of the members of the Association has cautioned those members against such activities, whether they be at meetings of the Association, at meetings of professional societies or other organizations, or otherwise.

The National Cooperative Research and Production Act of 1993

In November 1980, the Department of Justice (Antitrust Division) (the "DOJ") published the "Antitrust Guide Concerning Research Joint Ventures" (the "Guide" or the "1980 Guide"). The Guide assessed the antitrust laws in relation to joint research projects conducted by market competitors. However, the Guide was not as helpful to industry as the DOJ had anticipated. Instead, businesses continued to shy away from entering R&D joint ventures for fear of unfavorable DOJ evaluations and private institution of treble-damage actions.

Responding to these concerns, Congress passed The National Cooperative Research Act of 1984 (the "NCRA"). Congress intended that the NCRA would dispel the uncertainties surrounding enforcement of the antitrust laws under the 1980 Guide and thus encourage R&D joint ventures among competitors. In 1993 Congress amended and redesignated the NCRA as the National Cooperative Research and Production Act of 1993 (the "Act") to include certain forms of production joint ventures. By extending the Act to certain forms of production joint ventures, Congress aimed to promote innovation, facilitate trade, and strengthen the competitiveness of the United States in world markets.

Analysis of the Act

Three provisions of the Act make joint R&D or production activity among competitors more attractive. First, the Act provides that conduct falling within the definition of "joint venture" will be judged under the so-called "rule-of-reason."

Second, with respect to R&D activity, the Act exempts such activity from treble-damage suits, provided the participants in the research venture have made certain disclosures pursuant to a voluntary notification procedure. With respect to production joint ventures, the Act exempts such ventures from treble-damage suits provided two requirements are met in addition to the disclosure requirement: (1) the venture's production facilities must be located in the United States or its territories; and (2) the joint venturers and those parties who control the joint venturers must be either United States persons, or foreign persons from a country "whose law" accords parity of antitrust treatment to United States persons and domestic persons with respect to participation in production joint ventures.(1)

Finally, should private suits against the venture ensue, the Act permits awarding the venture costs, including reasonable attorney's fees, to the extent that the plaintiff's claim or conduct during the litigation was "frivolous, unreasonable, without foundation, or in bad faith."

Protected Activity

An R&D or production joint venture may bring itself within the protection of the Act only if the venture fits the Act's definition of a "joint venture". This term is both positively and negatively defined. Paraphrasing, "joint venture" specifically excludes from the Act's protection:

  • the exchange by competitors of information relating to costs, sales, profitability, prices, marketing, or distribution of any product, process or service that is not reasonably required to carry out the purpose of such venture;
  • joint production, marketing, or distribution of any product, process, or service, other than (1) the distribution among the parties to such venture, (2) the marketing of proprietary information developed through such venture formed under a written agreement entered into before June 10, 1993 (the effective date of the Act), or (3) the licensing, conveying, or transferring of intellectual property developed through such venture formed under a written agreement entered into on or after June 10, 1993;
  • any restriction or requirement relating to (1) the sale, licensing or sharing of developments, products, processes, or services not developed through, or produced by such venture, or (2) any person who is a party to such venture in other R&D activities, that is not reasonably required to prevent misappropriation of proprietary information contributed to or resulting from the venture;
  • any agreement or other conduct allocating a market with a competitor;
  • the exchange of information among competitors if such information is not reasonably required to carry out the purpose of such venture;
  • any restriction or requirement involving the production (other than the production by such venture) of a product, process, or service;
  • the use of existing facilities for the production of a product, process, or service unless such use involves the production of a new product or technology; and
  • except as provided above, any agreement or conduct restricting or requiring participation by any person who is a party to such venture, in any unilateral or joint activity not reasonably required to carry out the purpose of such venture.

Congress intended the exclusions to imply that when the sole purpose of the venture is to prepare a product for the marketplace, the protections of the Act are not available.

Conduct that does fall within the Act's definition of a "joint venture" includes:

  • theoretical analysis, experimentation, or systematic study of observable facts;
  • development or testing of basic engineering techniques;
  • extension of investigative findings or scientific theory to practical application for experimental or demonstrative purposes;
  • production of a product, process, or service;
  • testing in connection with the production of a product, process, or service by such venture;
  • collection, exchange, and analysis of research reproduction information; or
  • any combination of the above.

In addition, permissible conduct may include the establishment and operation of facilities for conducting such research, operating the venture on a proprietary basis, or licensing of or obtaining patents to cover the results of such research.

Standard of Review

Permissible conduct, if ever met with an antitrust challenge, will be judged by rule-of-reason analysis. Impermissible conduct does not automatically receive the same benefit, but will not necessarily be deemed per se illegal.

By authorizing rule-of-reason analysis, Congress has mandated that courts consider all relevant economic factors when evaluating the venture's effect on competition. This fluctuating standard permits courts to be sensitive to often rapid advances in technology, as well as changing global and domestic economic climates. Rule-of-reason analysis also recognizes that toleration of some degree of anticompetitive impact may be warranted depending on the value or complexity of any particular project.

Limited Remedy Where Venture Has Satisfied Public Disclosure Requirements

Should a venture's conduct, though falling within the Act's definition of "permissible", violate, under rule-of-reason analysis, Section 4 of the Clayton Act or similar state laws, recovery against the venture will be limited to actual damages where notice of the venture has been published in the Federal Register. Publication is obtained by filing a disclosure statement with the DOJ and the Federal Trade Commission ("FTC") describing the nature of the venture and identifying its participants.

In the case of a joint venture one of whose purposes is the production of a product, process, or service, the notification must contain additional information: the nationality of all parties and the identity and nationality of all persons who control any party to the venture whether separately or with one or more other persons acting as a group for the purpose of controlling such party. The term "control" means having the power to direct the management or policies of a person. This controlling influence may be exercised either directly or indirectly and the means used can vary.

Each participant must file the notice within 90 days of entering into a written agreement to conduct the venture.

The DOJ has promulgated a form of original and supplemental notice for the venture's disclosure of its nature and purpose to the DOJ and the FTC. The DOJ strongly urges that the participants to the venture draft their notice in the form provided to expedite its publication. The Premerger Notification Unit/FTC Liaison Office is responsible for review of the notice and forwards the notification to the appropriate section, task force or field office to determine whether it adequately identifies the parties to the venture and the venture's objectives.

After filing the notice but prior to publication, each member of the venture has the opportunity to review the proposed notice, which does not have to disclose any information that would result in competitive harm to the venture. Parties to the venture that review the draft notice have only two working days in which to express any objection to the notice before publication. If the members disapprove of the notice and cannot agree on its contents, the parties may withdraw notification. If the parties approve the contents, the FTC or DOJ must publish the notice within 30 days of receipt of the filings. If the DOJ fails to disapprove or publish the notice within thirty days of receipt, the venture can consider itself protected under NCRPA beginning on the expiration of the thirty-day period.

Publication, however, is not a governmental stamp of approval of the venture. Thus the venture remains obligated to police its activities and file notice again if membership in the venture changes, and the venture may not use publication as a defense to an antitrust suit. Publication, moreover, does not protect a venture that acts in violation of an injunction, DOJ consent decree, or FTC cease-and-desist order.

Finally, although the notification procedures limit recovery to actual damages, courts have the discretion to award prejudgment interest. Where just, such interest accrues from the earliest date that antitrust injury can be established.

Costs and Fees

Courts may award fees to a substantially prevailing claimant. Defendants are also protected. A defendant may receive a fee award, or offset a judgment in favor of the claimant, to the extent that the claimant acted unreasonably or in bad faith.

To date, no cases have been brought by federal or state agencies against a NCRPA reported joint venture. Only one private action has been initiated by an unsuccessful plaintiff. See Addamax Corp. v. Open Software Foundation, 888 F. Supp. 274 (D. Mass. 1995).

Since 1993, there have been several hundred joint ventures noticed in the Federal Register pursuant to NCRPA, however, only a relative few identify production of a product, process or service as one of their purposes. Several commentators blame the nationality restrictions in NCRPA for deterring parties interested in forming production joint ventures. Others claim that the problem stems from a lack of concrete guidelines for analyzing joint venture activity.

Recent Developments
Legislation

The Act is the result of a number of bills introduced in the U.S. House of Representatives over a three-year period seeking to clarify the treatment of production joint ventures under the antitrust laws and to eliminate unnecessary perceptual obstacles to their formation.

As noted above, the Act extends to production joint ventures the coverage and conditions of the NCRA, legislation that provided similar antitrust clarification for R&D joint ventures.

The FTC in conjunction with the DOJ conducted public hearings on June 5, 1997 and December 15, 1997 entitled the Joint Venture Project (the "JVP"). The issue addressed at these hearings was whether antitrust guidance to the business community can be improved through clarifying and updating antitrust policies regarding joint ventures and other forms of competitor collaborations. The JVP hearings also focused on the effectiveness of the NCRPA since its enactment.

The FTC and the DOJ hope to produce new antitrust guidelines or a series of policy statements for competitor collaborations that would be applicable to a wide variety of industry settings and flexible enough to apply as industries continue to evolve and innovate. To date, no formal guidelines or statements have evolved from the JVP hearings, and neither agency has indicated a possible publication date of any guidelines or statements. 

page 1  ·  page 2  ·  page 3  ·  page 4  ·  page 5

 

Home  ·  Introduction  ·  Our Clients  ·  Year in Review  ·  What's New  ·  Who's New  ·  Transactions
Practice Areas  ·  Attorneys  ·  Recruiting  ·  Publications  ·  Factors Software  ·  Contact Us  ·  Search


© Copyright 1999 Carter, Ledyard & Milburn
Disclaimer